<level type="section">
  <num>7-1651.01</num>
  <heading>Definitions.</heading>
  <text>For the purposes of this chapter, the term:</text>
  <level>
    <level>
      <num>(1)</num>
      <text>"CDC" means the Centers for Disease Control and Prevention.</text>
    </level>
    <level>
      <num>(2)</num>
      <text>"HPV" means the human papillomavirus.</text>
    </level>
  </level>
  <level>
    <type>annotations</type>
    <level>
      <heading>CREDIT(S)</heading>
      <text>(July 12, 2007, D.C. Law 17-10, ยง 2, 54 DCR 5146.)</text>
    </level>
    <level>
      <heading>HISTORICAL AND STATUTORY NOTES</heading>
      <level>
        <heading>Legislative History of Laws</heading>
        <text>Law 17-10, the "Human Papillomavirus Vaccination and Reporting Act of 2007", was introduced in Council and assigned Bill No. 17-30 which was referred to the Committee on Health. The Bill was adopted on first and second readings on April 3, 2007, and April 19, 2007, respectively. Signed by the Mayor on May 4, 2007, it was assigned Act No. 17-39 and transmitted to both Houses of Congress for its review. D.C. Law 17-10 became effective on July 12, 2007.</text>
      </level>
    </level>
  </level>
</level>
